Antidepressant use, pain severity and pain at multiple sites in patients with bruxism

Omar Franklin Molina; Zeila Coelho Santos; Rise Consolação luata Rank; Bruno Ricardo Huber Simião; Nayene Leocádia Manzutti Eid; Marcelo Bressan Corrêa; Karla Regina Gama

doi:10.5123/S2176-62232011000300002

Authors

Omar Franklin Molina Faculdade de Odontologia, Dor Orofacial e Odontopediatria, Centro Universitário UnirG, Gurupi, Tocantins, Brasil
Zeila Coelho Santos Faculdade de Odontologia, Dor Orofacial e Odontopediatria, Centro Universitário UnirG, Gurupi, Tocantins, Brasil
Rise Consolação luata Rank Faculdade de Odontologia, Dor Orofacial e Odontopediatria, Centro Universitário UnirG, Gurupi, Tocantins, Brasil
Bruno Ricardo Huber Simião Faculdade de Odontologia, Departamento de Prótese Dental e Clinica, Centro Universitário UnirG, Gurupi, Tocantins, Brasil
Nayene Leocádia Manzutti Eid Faculdade de Odontologia, Departamento de Prótese Dental e Clinica, Centro Universitário UnirG, Gurupi, Tocantins, Brasil
Marcelo Bressan Corrêa Departamento de Prótese e Implantes, Instituto Tocantinense Presidente Antônio Carlos, Araguaína, Tocantins, Brasil
Karla Regina Gama Departamento de Odontologia Clinica UNIRG, Gurupi, Tocantins, Brasil

DOI:

https://doi.org/10.5123/S2176-62232011000300002

Keywords:

Temporomandibular joint disorders, Bruxism, Facial pain, Antidepressant agents

Abstract

ABSTRACT

OBJECTIVE: The aim of this study was to compare the duration, pain severity, painful complaints and antidepressant use in patients with craniomandibular disorders (CMDs) and bruxing and control subjects.
MATERIAL AND METHODS: Clinical evaluation, questionnaires for pain, bruxism and antidepressant use, self-report of signs and symptoms and history regarding pain and muscle palpation were used to evaluate 389 patients presenting with CMDs and bruxing behavior and 69 controls.
RESULTS: The mean age of the experimental group was 33.3 years. The duration of the chief complaint was not different in the bruxism and CMD patients (Kruskal-Wallis test p = 0.13, which is non-significant). Severe pain was more frequently observed in the severe bruxing behavior subgroup (Chi-squared test for trends p = 0.01, significant). Patients with severe bruxism had used or were using more antidepressants than patients with mild or moderate bruxism and non-CMD control subjects (Chi-squared test for independence p = 0.006, significant). A greater number of pain complaints was observed in the severe bruxing behavior group (Kruskal-Wallis test p = 0.0001, extremely significant).
CONCLUSIONS: Patients with severe bruxism presented with a history of pain. Antidepressant use increased from the mild to the severe bruxing behavior group. In addition, the severe group demonstrated a greater number of painful complaints.